BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9377563)

  • 21. [Anti tumor activity of farnesyl transferase inhibitor].
    Yoshimatsu K; Nagasu T
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):145-55. PubMed ID: 9030225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro.
    Merryman JI; Capen CC; McCauley LK; Werkmeister JR; Suter MM; Rosol TJ
    Lab Invest; 1993 Sep; 69(3):347-54. PubMed ID: 8377475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
    Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
    Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitors of isoprenylation of ras p21].
    Yoshimatsu K
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1495-502. PubMed ID: 9309147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitors of Ras farnesylation: tomorrow's anticancer agents?].
    Perrin D; Halazy S; Hill B
    Bull Cancer; 1997 Jun; 84(6):635-42. PubMed ID: 9295868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
    Sanders JL; Chattopadhyay N; Kifor O; Yamaguchi T; Brown EM
    Biochem Biophys Res Commun; 2000 Mar; 269(2):427-32. PubMed ID: 10708570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
    Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
    Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
    Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
    J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased PTHRP production by a tyrosine kinase oncogene, Tpr-Met: role of the Ras signaling pathway.
    Aklilu F; Park M; Goltzman D; Rabbani SA
    Am J Physiol; 1996 Aug; 271(2 Pt 1):E277-83. PubMed ID: 8770021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.
    Omer CA; Chen Z; Diehl RE; Conner MW; Chen HY; Trumbauer ME; Gopal-Truter S; Seeburger G; Bhimnathwala H; Abrams MT; Davide JP; Ellis MS; Gibbs JB; Greenberg I; Koblan KS; Kral AM; Liu D; Lobell RB; Miller PJ; Mosser SD; O'Neill TJ; Rands E; Schaber MD; Senderak ET; Oliff A; Kohl NE
    Cancer Res; 2000 May; 60(10):2680-8. PubMed ID: 10825141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of the PTHrP gene in squamous carcinomas predicts the occurrence of hypercalcemia in athymic mice.
    Wysolmerski JJ; Vasavada R; Foley J; Weir EC; Burtis WJ; Kukreja SC; Guise TA; Broadus AE; Philbrick WM
    Cancer Res; 1996 Mar; 56(5):1043-9. PubMed ID: 8640759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
    Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
    J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
    J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR
    Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion.
    Cohen-Solal ME; Bouizar Z; Denne MA; Graulet AM; Gueris J; Bracq S; Jullienne A; de Vernejoul MC
    Horm Metab Res; 1995 Sep; 27(9):403-7. PubMed ID: 8557238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
    Bernhard EJ; Kao G; Cox AD; Sebti SM; Hamilton AD; Muschel RJ; McKenna WG
    Cancer Res; 1996 Apr; 56(8):1727-30. PubMed ID: 8620483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.